Search research articles
Contact Us
Filters
Showing results (91-100 of 111) with videos related to
Page
of 12
Sort By:
British Journal of Haematology
|
March 13, 2019
Correlation between high serum alkaline phosphatase levels and denosumab-related hypocalcemia in patients with multiple myeloma
Hirokazu Miki, Shingen Nakamura, Masahiro Oura, et al.
Antioxidants (Basel, Switzerland)
|
July 29, 2025
Pemafibrate Ameliorates Steatotic Liver Disease Regardless of Endothelial Dysfunction in Mice
Tomoyo Hara, Hiroki Yamagami, Ryoko Uemoto, et al.
International Journal of Molecular Sciences
|
June 19, 2024
Inflammatory Cytokine-Induced Muscle Atrophy and Weakness Can Be Ameliorated by an Inhibition of TGF-β-Activated Kinase-1
Mai Kanai, Byambasuren Ganbaatar, Itsuro Endo, et al.
Journal of Clinical Medicine
|
April 9, 2024
Causes of In-Hospital Death and Pharmaceutical Associations with Age of Death during a 10-Year Period (2011-2020) in Individuals with and without Diabetes at a Japanese Community General Hospital
Minae Hosoki, Taiki Hori, Yousuke Kaneko, et al.
Cancer Science
|
November 18, 2024
Elotuzumab-mediated ADCC with Th1-like Vγ9Vδ2 T cells to disrupt myeloma-osteoclast interaction
Yusuke Inoue, Hirofumi Tenshin, Jumpei Teramachi, et al.
Journal of Diabetes Investigation
|
May 27, 2021
Plasma heparin cofactor II activity is inversely associated with albuminuria and its annual deterioration in patients with diabetes
Tomoyo Hara, Ryoko Uemoto, Akiko Sekine, et al.
Journal of Atherosclerosis and Thrombosis
|
October 16, 2022
Plasma Heparin Cofactor II Activity Is Inversely Associated with Hepatic Fibrosis of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
Tomoyo Hara, Ryoko Uemoto, Akiko Sekine, et al.
Blood Advances
|
January 4, 2018
TAK1 inhibition subverts the osteoclastogenic action of TRAIL while potentiating its antimyeloma effects
Hirofumi Tenshin, Jumpei Teramachi, Asuka Oda, et al.
The Journal of Medical Investigation : JMI
|
October 16, 2022
An attempt to create a treatment algorithm of central adrenal insufficiency using CRH test, DHEA-S and clinical evaluation
Yukari Mitsui, Yuto Iizuka, Tomoaki Tanaka, et al.
British Journal of Haematology
|
November 27, 2018
Class 1 HDAC and HDAC6 inhibition inversely regulates CD38 induction in myeloma cells via interferon-α and ATRA
Ariunzaya Bat-Erdene, Shingen Nakamura, Asuka Oda, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 111) with videos related to
Sort By:
Page
of 12
British Journal of Haematology
|
March 13, 2019
Correlation between high serum alkaline phosphatase levels and denosumab-related hypocalcemia in patients with multiple myeloma
Hirokazu Miki, Shingen Nakamura, Masahiro Oura, et al.
Antioxidants (Basel, Switzerland)
|
July 29, 2025
Pemafibrate Ameliorates Steatotic Liver Disease Regardless of Endothelial Dysfunction in Mice
Tomoyo Hara, Hiroki Yamagami, Ryoko Uemoto, et al.
International Journal of Molecular Sciences
|
June 19, 2024
Inflammatory Cytokine-Induced Muscle Atrophy and Weakness Can Be Ameliorated by an Inhibition of TGF-β-Activated Kinase-1
Mai Kanai, Byambasuren Ganbaatar, Itsuro Endo, et al.
Journal of Clinical Medicine
|
April 9, 2024
Causes of In-Hospital Death and Pharmaceutical Associations with Age of Death during a 10-Year Period (2011-2020) in Individuals with and without Diabetes at a Japanese Community General Hospital
Minae Hosoki, Taiki Hori, Yousuke Kaneko, et al.
Cancer Science
|
November 18, 2024
Elotuzumab-mediated ADCC with Th1-like Vγ9Vδ2 T cells to disrupt myeloma-osteoclast interaction
Yusuke Inoue, Hirofumi Tenshin, Jumpei Teramachi, et al.
Journal of Diabetes Investigation
|
May 27, 2021
Plasma heparin cofactor II activity is inversely associated with albuminuria and its annual deterioration in patients with diabetes
Tomoyo Hara, Ryoko Uemoto, Akiko Sekine, et al.
Journal of Atherosclerosis and Thrombosis
|
October 16, 2022
Plasma Heparin Cofactor II Activity Is Inversely Associated with Hepatic Fibrosis of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
Tomoyo Hara, Ryoko Uemoto, Akiko Sekine, et al.
Blood Advances
|
January 4, 2018
TAK1 inhibition subverts the osteoclastogenic action of TRAIL while potentiating its antimyeloma effects
Hirofumi Tenshin, Jumpei Teramachi, Asuka Oda, et al.
The Journal of Medical Investigation : JMI
|
October 16, 2022
An attempt to create a treatment algorithm of central adrenal insufficiency using CRH test, DHEA-S and clinical evaluation
Yukari Mitsui, Yuto Iizuka, Tomoaki Tanaka, et al.
British Journal of Haematology
|
November 27, 2018
Class 1 HDAC and HDAC6 inhibition inversely regulates CD38 induction in myeloma cells via interferon-α and ATRA
Ariunzaya Bat-Erdene, Shingen Nakamura, Asuka Oda, et al.
Page
of 12